Cytovax is an emerging Canadian biotechnology company focusing on the development and commercialization of vaccines and therapeutic products for the prevention and treatment of infectious diseases.

Full architectural services for this growing biotechnology company were provided by Manasc Isaac. The laboratories were designed to Good Manufacturing Practices (GMP) standards, required by laboratories producing pharmaceuticals for clinical trials and experimental purposes.